Wells Fargo & Company Zynerba Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.33 - $1.39 $24,236 - $102,085	-73,443 Reduced 96.75%	2,464 $3,000
Q2 2023 Aug 15, 2023	SELL	$0.3 - $0.43 $21,247 - $30,455	-70,826 Reduced 48.27%	75,907 $25,000
Q1 2023 May 12, 2023	BUY	$0.4 - $0.67 $35,451 - $59,381	88,629 Added 152.54%	146,733 $63,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $0.72 $15,357 - $22,114	-30,714 Reduced 34.58%	58,104 $30,000
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $184 - $288	212 Added 0.24%	88,818 $64,000
Q2 2022 Aug 12, 2022	BUY	$0.86 - $2.06 $25,087 - $60,094	29,172 Added 49.08%	88,606 $101,000
Q1 2022 May 16, 2022	BUY	$1.83 - $3.02 $43,802 - $72,286	23,936 Added 67.43%	59,434 $123,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $967 - $1,444	-336 Reduced 0.94%	35,498 $102,000
Q3 2021 Nov 15, 2021	BUY	$3.72 - $5.35 $1,882 - $2,707	506 Added 1.43%	35,834 $151,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $24,512 - $38,272	6,400 Added 22.12%	35,328 $186,000
Q1 2021 May 13, 2021	BUY	$3.33 - $8.76 $88,105 - $231,772	26,458 Added 1071.17%	28,928 $134,000
Q4 2020 Feb 09, 2021	BUY	$3.27 - $4.64 $2,717 - $3,855	831 Added 50.7%	2,470 $8,000
Q3 2020 Nov 05, 2020	SELL	$3.23 - $4.3 $9,018 - $12,005	-2,792 Reduced 63.01%	1,639 $5,000
Q2 2020 Aug 13, 2020	SELL	$3.31 - $6.54 $59,225 - $117,020	-17,893 Reduced 80.15%	4,431 $15,000
Q1 2020 May 14, 2020	BUY	$2.9 - $6.16 $64,739 - $137,515	22,324 New	22,324 $86,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.